abc27

GORE RELEASES 3-YEAR DATA FOR THE GORE® CARDIOFORM ASD OCCLUDER

Gore ASSURED Clinical Study results through 36 months demonstrate 100 percent closure success * with the GORE ® CARDIOFORM ASD Occluder, and consistent safety outcomes † across a broad range of ASD ...
WAVY-TV

THE GORE RELIEF CLINICAL STUDY BEGINS RANDOMIZING PATIENTS TO EVALUATE PFO CLOSURE FOR MIGRAINE HEADACHE RELIEF

CAUTION: Investigational device. Limited by United States law to investigational use. The Gore RELIEF Clinical Study is evaluating the safety and efficacy of transcatheter closure of patent foramen ...
TCTMD

Treatment of Residual Shunt After PFO Closure Using Mullins Sheath-Facilitated Delivery of the Gore Cardioform Septal Occluder Device

Prophylactic VA-ECMO for TAVI Using Self-Expandable Valves in Patients With Cardiogenic Shock and a Left Ventricular Ejection Fraction Below 30% Receive the the latest news, research, and ...
TCTMD

Multiple ASD Closure Using the Interleaving Method: A Refined Strategy Utilizing Gore Cardioform Occluder Devices

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Becker's ASC

SGMC Health caps milestone heart procedure

Valdosta, Ga.-based SGMC Health completed its first patent foramen ovale closure procedure at its heart and vascular center. The procedure was performed by interventional cardiologist Daryoosh ...